Purpose: The cost of darbepoetin alfa versus that of epoetin alfa in a hospital setting was studied. Methods: The study was an observational, retrospective review of the hospitalwide use of ...

The main causes of anemia are deficient production of erythropoietin (EPO), iron deficiency, and chronic disease with endogenous EPO resistance. EPO has been successfully used for over a decade to ...

Routine administration of recombinant erythropoietin to patients on hemodialysis has greatly facilitated the management of chronic-kidney-disease-induced anemia. However, this glycoprotein hormone ...

We did not control for this potential confounder, since our focus was on hospitalwide use of darbepoetin and epoetin, regardless of the clinical outcomes directly related to their use. Another ...